Background
Aim
Methods
Design
Participants
Intervention
Data collection
Part 1
Part 2
Ethical considerations
Data analysis
Validity and reliability
Results
Part 1
Availability of the intervention
Part 2
Participants and response
Patients
| ||
---|---|---|
Number | 77 | |
Age | (mean in years + SD) | 72.5 (9.6) |
Gender | (male/%) | 41/53.2% |
Time since stroke | (mean in months + SD) | 1.8 (1.4) |
Discharged from (N/%) | Hospital | 52/67.5% |
Inpatient rehabilitation | 25/32.5% | |
Caregivers
| ||
Number | 59 | |
Age | (mean in years + SD) | 61.5 (14.7) |
Gender | (male/%) | 18/30.5% |
Relationship | Spouse | 36/61.0% |
Child | 17/28.8% | |
Other | 6/10.2% |
Performance of the intervention
Home Visits (N = 5) | ||
Range (N) | 1-7 | |
Average home visits (SD) | 3.8 (1.5) | |
One home visit | 7 | 9% |
Two home visits | 10 | 13% |
Three home visits | 12 | 16% |
Four home visits | 20 | 26% |
Five home visits | 20 | 26% |
Six or more home visits | 8 | 10% |
Follow-up period (18 months intended) | N | % |
Range (months) | 1-27 | |
Mean (months, SD) | 13.3 (6.9) | |
Maximum follow-up period of 1 month | 6 | 8% |
Maximum follow-up period of 3 months | 5 | 7% |
Maximum follow-up period of 6 months | 9 | 12% |
Maximum follow-up period of 12 months | 15 | 19% |
Maximum follow-up period of 18 months | 31 | 40% |
Follow-up period longer than 18 months | 11 | 14% |
Home visits and follow-up period in accordance with the protocol | ||
1st home visit within 0-1 month | 66 | 86% |
2nd home visit within 2-4 months | 46 | 60% |
3rd home visit within 5-7 months | 26 | 34% |
4th home visit within 11-13 months | 22 | 29% |
5th home visit within 17-19 months | 16 | 21% |
Follow-up care based on assessment
0-1 months (N = 66)
|
2-4 months (N = 53)
|
5-7 months (N = 40)
|
11-13 months (N = 32)
|
17-19 months (N = 17)
| ||||||
---|---|---|---|---|---|---|---|---|---|---|
Problem
|
%*
|
Problem
|
%*
|
Problem
|
%*
|
Problem
|
%*
|
Problem
|
%*
| |
1 | Fatigue | 79 | Fatigue | 68 | IADL | 55 | Fatigue | 53 | Fatigue | 53 |
2 | IADL | 64 | IADL | 64 | Fatigue | 50 | IADL | 47 | Cognition | 47 |
3 | Cognition | 56 | Cognition | 57 | Cognition | 38 | Cognition | 44 | IADL | 47 |
4 | Medical status | 52 | Social activity | 49 | Medical status | 38 | Communication | 41 | Communication | 44 |
5 | Communication | 45 | Communication | 43 | ADL | 33 | Social activity | 38 | Medical status | 41 |
6 | Social activity | 44 | Medical status | 42 | Social activity | 28 | Psycho-emotional | 31 | Psycho-emotional | 24 |
Opinions of patients and caregivers
Patients
Patients
|
T0
|
T6
|
T12
|
T18
| |
---|---|---|---|---|---|
SASC-19, part 1* | N | 68 | 54 | 54 | 53 |
Mean (SD) | 2.4 (0.4) | 2.5 (0.5) | 2.5 (0.5) | 2.6 (0.5) | |
Score >1.5** (%) | 100% | 100% | 100% | 100% | |
SASC-19, part 2* | N | 69 | 59 | 61 | 64 |
Mean (SD) | 1.9 (0.3) | 1.9 (0.2) | 1.9 (0.2) | 2.0 (0.2) | |
Score >1.5 (%) | 91.3% | 96.6% | 95.1% | 97.9% | |
Caregivers | |||||
SASC-19, part 1* | N | 47 | 33 | 32 | 34 |
Mean (SD) | 2.4 (0.5) | 2.5 (0.5) | 2.6 (0.5) | 2.6 (0.5) | |
Score >1.5** (%) | 97.9% | 100% | 96.9% | 94.1% | |
SASC-19, part 2* | N | 54 | 38 | 36 | 38 |
Mean (SD) | 1.9 (0.4) | 2.0 (0.4) | 2.1 (0.3) | 2.0 (0.4) | |
Score >1.5** (%) | 88.9% | 94.7% | 97.2% | 97.4% |